GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 785 filers reported holding GLAXOSMITHKLINE PLC in Q1 2018. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $17,728,000 | -55.6% | 407,266 | -55.0% | 0.05% | -50.0% |
| Q4 2021 | $39,900,000 | -68.6% | 904,766 | -72.8% | 0.10% | -69.6% |
| Q3 2021 | $126,948,000 | +5189.5% | 3,322,366 | +5412.8% | 0.33% | +5383.3% |
| Q2 2021 | $2,400,000 | -91.2% | 60,266 | -92.2% | 0.01% | -92.0% |
| Q1 2021 | $27,412,000 | +516.3% | 768,066 | +535.5% | 0.08% | +525.0% |
| Q4 2020 | $4,448,000 | -93.5% | 120,866 | -93.3% | 0.01% | -93.8% |
| Q3 2020 | $67,988,000 | -33.0% | 1,806,266 | -27.4% | 0.19% | -34.9% |
| Q2 2020 | $101,435,000 | +481.9% | 2,486,766 | +440.5% | 0.30% | +344.8% |
| Q1 2020 | $17,432,000 | +843.8% | 460,066 | +1070.7% | 0.07% | +1575.0% |
| Q4 2019 | $1,847,000 | -90.4% | 39,300 | -91.3% | 0.00% | -91.5% |
| Q3 2019 | $19,269,000 | +26.6% | 451,466 | +18.7% | 0.05% | +23.7% |
| Q2 2019 | $15,226,000 | -47.6% | 380,466 | -45.3% | 0.04% | -47.9% |
| Q1 2019 | $29,080,000 | +16.5% | 695,866 | +6.5% | 0.07% | +7.4% |
| Q4 2018 | $24,969,000 | -5.3% | 653,466 | -0.5% | 0.07% | +6.2% |
| Q3 2018 | $26,380,000 | -34.4% | 656,700 | -34.1% | 0.06% | -40.7% |
| Q2 2018 | $40,199,000 | -54.5% | 997,242 | -55.9% | 0.11% | -55.0% |
| Q1 2018 | $88,437,000 | -50.9% | 2,263,542 | -55.4% | 0.24% | -50.5% |
| Q4 2017 | $179,998,000 | +35.9% | 5,074,642 | +55.5% | 0.48% | +29.0% |
| Q3 2017 | $132,488,000 | +12.0% | 3,263,242 | +19.0% | 0.38% | -3.6% |
| Q2 2017 | $118,276,000 | +18.2% | 2,742,942 | +15.6% | 0.39% | +18.9% |
| Q1 2017 | $100,077,000 | +6.3% | 2,373,742 | -2.9% | 0.33% | -8.9% |
| Q4 2016 | $94,109,000 | +1233.4% | 2,443,742 | +1393.3% | 0.36% | +1100.0% |
| Q3 2016 | $7,058,000 | +731.3% | 163,642 | +734.9% | 0.03% | +650.0% |
| Q2 2016 | $849,000 | -79.8% | 19,600 | -81.1% | 0.00% | -83.3% |
| Q1 2016 | $4,213,000 | -65.7% | 103,900 | -67.5% | 0.02% | -69.2% |
| Q3 2015 | $12,299,000 | -64.2% | 319,866 | -61.3% | 0.08% | -70.6% |
| Q2 2015 | $34,384,000 | +83.2% | 825,542 | +103.0% | 0.26% | +84.0% |
| Q1 2015 | $18,766,000 | -38.7% | 406,622 | -43.2% | 0.14% | -41.2% |
| Q4 2014 | $30,599,000 | -50.5% | 715,922 | -46.8% | 0.24% | -49.8% |
| Q3 2014 | $61,872,000 | +23.7% | 1,345,922 | +43.9% | 0.49% | +24.5% |
| Q2 2014 | $50,021,000 | +19.1% | 935,322 | +19.0% | 0.39% | +2.6% |
| Q1 2014 | $41,996,000 | +135.2% | 786,022 | +135.0% | 0.38% | +122.1% |
| Q4 2013 | $17,859,000 | +100.2% | 334,522 | +88.1% | 0.17% | +62.3% |
| Q3 2013 | $8,922,000 | +9.4% | 177,822 | +9.0% | 0.11% | -9.4% |
| Q2 2013 | $8,156,000 | – | 163,190 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |